BioSpace News Archive

Phio Pharmaceuticals Corp. today announced that its Chief Executive Officer, Dr. Gerrit Dispersyn, will participate in the H.C. Wainwright Virtual BioConnect 2022 Conference, which is being held on January 10 – 13, 2022.

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that company management will participate in a panel presentation and one-on-one investor meetings at the 11th Annual LifeSci Partners Corporate Access Event.

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), today announced that David Cory, President and CEO, will provide a corporate update at the H.C. Wainwright BioConnect 2022 Virtual Conference.

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) for the Company’s lead drug candidate, REQORSA™ Immunogene Therapy, in combination with Merck & Co’s Keytruda®

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference.

According to Emergen Research, the global patient registry software market size was USD 1.10 Billion in 2019 and is expected to reach USD 2.96 Billion in 2027 and register a revenue CAGR of 13.9% during the forecast period, 2020-2027.

The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and ML to enhance efficiency of medical products.

The industry analysis report is considered a valuable source of information about the global Bovine Vaccines industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and ML to enhance efficiency of medical products.

ILiAD Biotechnologies today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BPZE1, a next generation vaccine for active booster immunization against pertussis.